We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

EUROIMMUN AG

EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecula... read more Featured Products: More products

Download Mobile App




Multiparameter Autoantibody Detection Aids Diagnosis of Myositis

By LabMedica International staff writers
Posted on 12 Jul 2023
Print article
Image: EUROBlotOne for fully automated immunoblot analyses (Photo courtesy of EUROIMMUN)
Image: EUROBlotOne for fully automated immunoblot analyses (Photo courtesy of EUROIMMUN)

Idiopathic inflammatory myopathies (IIM), or myositides, are a collection of systemic autoimmune rheumatic diseases. These disorders are characterized by chronic inflammation of the skeletal muscle, and in some instances, can be linked to cancer. Due to their rarity, resemblance to other rheumatic diseases, and the potential for overlap syndromes, diagnosing IIMs can be complex. Pinpointing the exact subtype of the disease is crucial due to diverse treatment options. Autoantibodies are critical diagnostic biomarkers for IIM and help in identifying disease subtypes. The German Society for Neurology (DGN) issued guidelines in 2022, mandating the identification of myositis-specific autoantibodies (MSA) and myositis-associated autoantibodies (MAA) as a diagnostic step. Given the low prevalence and frequent isolation of IIM autoantibodies, antibody detection must be as comprehensive as possible.

EUROIMMUN (Lübeck, Germany) has developed a line blot (EUROLINE Autoimmune Inflammatory Myopathies 20 Ag Profile) that uniquely combines 20 nuclear and cytoplasmic antigens. This assists in detecting and differentiating autoantibodies in IIM, making it the most comprehensive commercially available line blot for IIM diagnostics. The antigen portfolio encompasses the MSA target antigens Zo, Ks, Ha, cN-1A, OJ, EJ, PL-12, PL-7, SRP, Jo-1, SAE1, NXP2, MDA5, TIF1γ, Mi-2α and Mi-2β and the MAA target antigens Ku, PM-Scl75, PM-Scl100 and Ro-52, each printed onto separate membrane chips for optimal antibody detection efficiency. The immunoblot analysis is particularly effective in identifying autoantibodies against cytoplasmic antigens, which other methods such as indirect immunofluorescence can miss. The assay process and result evaluation can be fully automated.

This specific antibody detection approach aids in diagnosing IIM subforms in light of clinical symptoms. Notably, anti-cN-1A is the sole known serological marker for sporadic inclusion body myositis (sIBM). Since anti-cN-1A is rarely found in other IIMs, its detection can help distinguish sIBM from other IIM forms, aiding in early diagnosis. The EUROLINE is the sole commercial line blot that includes this antigen. The antigens Zo, Ks, and Ha supplement the tRNA synthetase antigen spectrum for differential diagnosis of anti-synthetase syndrome (ASS) along with EJ, OJ, PL-12, PL-7, Jo-1, and SRP. Current research is exploring the link of antibodies against Zo, Ks, and Ha with interstitial lung disease. Autoantibodies against Mi-2α, Mi-2β, NXP2, TIF1γ, SAE1, and MDA5 are indicative of dermatomyositis (DM), with anti-NXP2 and anti-TIF1γ often associated with malignancies. Antibodies against Ku, PM-Scl-75, and PM-Scl100 are typically found in overlap syndromes, while anti-SRP is present in necrotizing myositis. Detecting specific autoantibodies can significantly accelerate diagnosis, enabling prompt therapeutic intervention. Autoantibody profiling also helps in assessing malignancy risk and predicting therapy outcomes.

Related Links:
EUROIMMUN 

Platinum Supplier
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Gold Supplier
Parainfluenza Virus Test
PARAINFLUENZA ELISA
New
Near-Patient Testing Platform
FINDER
New
Measles Virus Antibody Test
Chorus MEASLES IgG

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Microbiology

view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more

Pathology

view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.